Colon, lung, and liver cancers are among the most prevalent and lethal cancers globally. Despite advancements in treatment, these cancers continue to pose significant challenges due to high mortality ...
(A) Multiple environmental and genetic factors have been associated with MASLD. Most significant ones are highlighted here. (B) Several strong genetic risk factors for MASLD are highlighted here. ALT, ...
Analysis of Alzheimer’s brains revealed age-related accumulation of cancer driver mutations, particularly in microglia. These ...
New research from Boston Children’s Hospital, published in Cell, finds that the brain’s resident immune cells, microglia, amass mutations in specific cancer-driving genes yet they don’t manifest as ...
Methodology for estimation of progression-free survival in patients with non-small cell lung cancer using real-world data from a French cohort. This is an ASCO Meeting Abstract from the 2025 ASCO ...
A research team at the University of Cologne's Center for Molecular Medicine Cologne (CMMC) has discovered that the protein ...
Unraveling the role of ubiquitin C-terminal hydrolase L1 in high grade serous ovarian cancer pathogenesis. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not ...
Researchers are rethinking how we target bowel cancer growth pathways, using patient-derived organoids to identify whether hyperactivating growth genes, rather than inhibiting them, improves outcomes.
In a joint funding initiative, NHMRC and Cancer Australia are investing $15 million into high quality health and medical research to enhance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results